Dimensional Fund Advisors

Dimensional Fund Advisors Portfolio holdings

AUM $432B
 

Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.

This Quarter Return
+8.5%
1 Year Return
+19.15%
3 Year Return
+80.48%
5 Year Return
+182.76%
10 Year Return
+378.45%
AUM
$412B
AUM Growth
+$412B
Cap. Flow
+$5.4B
Cap. Flow %
1.31%
Top 10 Hldgs %
15.23%
Holding
3,437
New
64
Increased
1,714
Reduced
1,456
Closed
88

Sector Composition

1 Technology 19.73%
2 Financials 17.51%
3 Industrials 12.49%
4 Consumer Discretionary 10.71%
5 Healthcare 10.22%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
DZSI
3351
DELISTED
DZS Inc. Common Stock
DZSI
-82,913 Closed -$97.3K
ATRI
3352
DELISTED
Atrion Corp
ATRI
-31,912 Closed -$14.4M
ABCL icon
3353
AbCellera Biologics
ABCL
$1.25B
-179,882 Closed -$532K
AHH
3354
Armada Hoffler Properties
AHH
$584M
-33,111 Closed -$367K
ANIX icon
3355
Anixa Biosciences
ANIX
$96.3M
-17,544 Closed -$38.8K
ANTX icon
3356
AN2 Therapeutics
ANTX
$30.1M
-25,150 Closed -$54.1K
APLS icon
3357
Apellis Pharmaceuticals
APLS
$3.48B
-33,696 Closed -$1.29M
AQB icon
3358
AquaBounty Technologies
AQB
$4.58M
-12,770 Closed -$21.2K
BIRD icon
3359
Allbirds
BIRD
$52.4M
-16,206 Closed -$8.1K
BKSY icon
3360
BlackSky Technology
BKSY
$623M
-20,736 Closed -$22.2K
BNGO icon
3361
Bionano Genomics
BNGO
$17.6M
-30,996 Closed -$21K
CABA icon
3362
Cabaletta Bio
CABA
$133M
-17,516 Closed -$131K
CRMD icon
3363
CorMedix
CRMD
$1.11B
-21,601 Closed -$93.5K
DALN icon
3364
DallasNews
DALN
$79.8M
-33,897 Closed -$122K
DNTH icon
3365
Dianthus Therapeutics
DNTH
$759M
-19,726 Closed -$510K
ELEV
3366
DELISTED
Elevation Oncology
ELEV
-72,985 Closed -$197K
ETON icon
3367
Eton Pharmaceutcials
ETON
$464M
-10,564 Closed -$34.8K
GLPG icon
3368
Galapagos
GLPG
$2.07B
-28,774 Closed -$713K
KOSS icon
3369
Koss Corp
KOSS
$58.1M
-145,958 Closed -$650K
LNKB icon
3370
LINKBANCORP
LNKB
$273M
-13,613 Closed -$83.3K
LYRA icon
3371
Lyra Therapeutics
LYRA
$11.5M
-21,471 Closed -$5.94K
MRSN icon
3372
Mersana Therapeutics
MRSN
$36.5M
-13,703 Closed -$27.5K
MURA icon
3373
Mural Oncology
MURA
$35.7M
-22,563 Closed -$70.8K
NINE icon
3374
Nine Energy Service
NINE
$29.8M
-89,836 Closed -$151K
OM icon
3375
Outset Medical
OM
$247M
-142,290 Closed -$548K